Fuhrman Alan received 951 Tyra Biosciences shares at $9.13 each, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding, giving investors the reported size of the award and the executive’s post-transaction position.

Key Highlights

  • Fuhrman Alan’s Tyra Biosciences award was priced at $9.13 per share.
  • The transaction left the executive with 37,115 Tyra Biosciences shares.
  • SEC transaction code A classifies the event as an award or grant.

Fuhrman Alan received 951 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 each on 15 September 2026, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding. Alan is Tyra Biosciences’ Chief Financial Officer.

Award Adds 951 Tyra Biosciences Shares

His ownership after the transaction stood at 37,115 shares. The entry was dated 15 September 2026. The award involved Fuhrman Alan directly.